Compare Novartis AG (NVS) vs Vale SA (VALE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs Vale SA — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Vale SA trades at $14.13 (market cap $59.07B). The key difference: Novartis AG is far larger — about 4.9× Vale SA's market cap, and Vale SA pays the higher dividend (8.93%). Which is the better fit depends on your goals.
| NVS | VALE | |
|---|---|---|
Market Cap | $290.25B | $59.07B |
Sector | Health | Basic Materials |
52-Week High | $168.62 | $17.82 |
52-Week Low | $113.50 | $9.53 |
Enterprise Value | $330.27B | $75.99B |
Dividend Yield | 3.17% | 8.93% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About Vale SA
Vale is the world's largest iron ore miner and one of the largest diversified miners, along with BHP and Rio Tinto. Earnings are dominated by the bulk materials division, primarily iron ore and iron ore pellets, with minor contributions from iron ore proxies, including manganese and coal. The base metals division is much smaller, primarily consisting of nickel mines and smelters with a small contribution from copper.
Read more on VALE →
